Cite
HARVARD Citation
Facchinetti, F. et al. (2020). First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status. European journal of cancer. pp. 155-167. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Facchinetti, F. et al. (2020). First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status. European journal of cancer. pp. 155-167. [Online].